Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;30(14):1954-62.
doi: 10.1177/0883073815600870. Epub 2015 Aug 24.

Cerebellar Development and Autism Spectrum Disorder in Tuberous Sclerosis Complex

Affiliations
Review

Cerebellar Development and Autism Spectrum Disorder in Tuberous Sclerosis Complex

Maria Sundberg et al. J Child Neurol. 2015 Dec.

Abstract

Approximately 50% of patients with the genetic disease tuberous sclerosis complex present with autism spectrum disorder. Although a number of studies have investigated the link between autism and tuberous sclerosis complex, the etiology of autism spectrum disorder in these patients remains unclear. Abnormal cerebellar function during critical phases of development could disrupt functional processes in the brain, leading to development of autistic features. Accordingly, the authors review the potential role of cerebellar dysfunction in the pathogenesis of autism spectrum disorder in tuberous sclerosis complex. The authors also introduce conditional knockout mouse models of Tsc1 and Tsc2 that link cerebellar circuitry to the development of autistic-like features. Taken together, these preclinical and clinical investigations indicate the cerebellum has a profound regulatory role during development of social communication and repetitive behaviors.

Keywords: Purkinje cell; cerebellum; magnetic resonance imaging; mechanistic target of rapamycin; mouse models.

PubMed Disclaimer

References

    1. Kwiatkowski DJ, Whittemore VH, Thiele EA, editors. Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics. 1st ed. Weinheim: Wiley-VCH; 2010. p. 409.
    1. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345–1356. - PubMed
    1. Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;84:275–291. - PMC - PubMed
    1. Mizuguchi M, Takashima S. Neuropathology of tuberous sclerosis. Brain Dev. 2001;23:508–515. - PubMed
    1. Goodman M, Lamm SH, Engel A, et al. Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol. 1997;12:85–90. - PubMed

Publication types

MeSH terms

Substances